LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,069 | -97.2% | 4,110 | -97.1% | 0.00% | -96.9% |
| Q2 2023 | $9,756,700 | +208.3% | 141,340 | +123.0% | 0.06% | +261.1% |
| Q4 2022 | $3,164,279 | +624.1% | 63,387 | +492.4% | 0.02% | +800.0% |
| Q3 2022 | $437,000 | -90.0% | 10,700 | -86.6% | 0.00% | -92.6% |
| Q2 2022 | $4,384,000 | +131.5% | 79,709 | +52.9% | 0.03% | +68.8% |
| Q1 2022 | $1,894,000 | +32.8% | 52,130 | +70.4% | 0.02% | +14.3% |
| Q4 2021 | $1,426,000 | -48.9% | 30,600 | -44.5% | 0.01% | -60.0% |
| Q3 2021 | $2,790,000 | -22.3% | 55,183 | -36.9% | 0.04% | -12.5% |
| Q2 2021 | $3,590,000 | +1224.7% | 87,458 | +807.3% | 0.04% | +900.0% |
| Q4 2020 | $271,000 | +7.5% | 9,639 | +18.2% | 0.00% | 0.0% |
| Q3 2020 | $252,000 | +3050.0% | 8,153 | +4454.7% | 0.00% | – |
| Q2 2020 | $8,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |